Cost considerations in short course chemotherapy

Sivaraman, V. (1983) Cost considerations in short course chemotherapy. Indian Journal of Tuberculosis, 30 (1). pp. 8-15.

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
322 Kb

Abstract

The cost implications of some short course chemotherapy regimens are analysed. A methodology for quantification of the benefits of short course chemotherapy taking into account the cost per stable quiescence of some regimens is outlined—other benefits quantified are better response in those who abscond early, those with initial drug resistance and easier amenability of failures to re-treatment it. The study shows that some short course regimens may potentially be cost wise comparable to conventional regimens.

EPrint Type:Article
Uncontrolled Keywords:Cost Implications, Short Course Chemotherapy, Drug Resistance, I N H ,Pyrazinamide , Rifampicin , Thiacetazone, P.A.S., Ethambutol, Tuberculosis
Subjects:Bacterial Infections and Mycoses > Bacterial Infections > Gram-Positive Bacterial Infections > Actinomycetales Infections > Mycobacterium Infections > Tuberculosis
Therapeutics > Drug Therapy
Diagnosis > Prognosis
Organic Chemicals > Hydrazines > Isoniazid
Organic Chemicals > Amines > Polyamines
Heterocyclic Compounds > Heterocyclic Compounds with 4 or More Rings > Rifamycins
Health Care Quality, Access, and Evaluation > Quality of Health Care
Organic Chemicals > Carboxylic Acids > Hydroxy Acids > Hydroxybenzoic Acids > Salicylic Acids > Aminosalicylic Acids > p-Aminosalicylic Acid
Health Services Administration > Quality of Health Care
Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrazines
Organic Chemicals > Sulfur Compounds > Thiosemicarbazones
-Journal Repositories > Indian Journal of Tuberculosis
Social Sciences > Economics
Health Care Economics and Organizations > Economics
ID Code:2594
Deposited By:Mrs Naina Pandita
Deposited On:20 February 2008

Archive Staff Only: edit this record